Try our Advanced Search for more refined results

Federal Trade Commission et al v. Actavis, Inc.

  1. February 28, 2019

    Original FTC V. Actavis Case Ends With AbbVie AndroGel Deal

    AbbVie Inc. has agreed not to enter settlements that illegally delay the entry of certain generic drugs, allowing it to avoid a related trial over its testosterone treatment AndroGel slated to start Monday and officially putting an end to the landmark Federal Trade Commission v. Actavis litigation, the agency said Thursday.

  2. February 20, 2019

    FTC's Teva Settlement A Sign Of Enforcement Evolution

    The Federal Trade Commission's settlement this week with Teva Pharmaceuticals further winnows the types of deals the company can sign with would-be competitors and illuminates the agency's evolving approach to cases in which drug companies are accused of colluding to delay competition.

  3. February 19, 2019

    FTC Pens New Deal With Teva On Reverse-Payment Claims

    The Federal Trade Commission said Tuesday it has reached an agreement with Teva Pharmaceuticals that would prevent the drugmaker from entering into certain reverse-payment patent settlements that can delay the availability of generic versions of drugs.

  4. February 05, 2019

    FTC Permitted To Force Exec Testimony In AndroGel Trial

    When the Federal Trade Commission goes to trial next month with allegations that AbbVie Products LLC and Actavis Inc. conspired to delay generic versions of the testosterone drug AndroGel, it will do so with the testimony of pharmaceutical executives, which a Georgia federal judge on Monday allowed the agency to force.

  5. January 11, 2019

    FTC Must Appear In AndroGel Case Despite Shutdown

    A Georgia federal judge on Thursday ordered the Federal Trade Commission to appear at a hearing for its long-running case accusing drugmakers of conspiring to delay generic versions of the testosterone drug AndroGel, despite a government shutdown that has the agency running on a skeleton crew.

  6. December 10, 2018

    Pharmas Say FTC Pushing Subpoena Limits In AndroGel Row

    The Federal Trade Commission can't justify its call for nationwide subpoena power in the agency's suit alleging the makers of testosterone drug AndroGel cut deals with generic companies to delay competition, two drugmakers argued in Georgia federal court.

  7. August 23, 2018

    FTC Scores Separate Trial In AndroGel Antitrust Row

    A Georgia federal judge on Wednesday agreed to let the Federal Trade Commission have a separate bench trial from drug retailers in a decade-old antitrust suit over whether drugmakers conspired to delay generic versions of testosterone drug AndroGel through settlements in patent litigation.

  8. August 21, 2018

    FTC Pushes For Separate Trial In AndroGel Antitrust Suit

    The Federal Trade Commission has said it wants a separate trial from private buyers and retailers in a decade-old antitrust suit over whether drugmakers conspired to delay generic versions of testosterone drug AndroGel through patent settlements, telling a Georgia federal judge that a combined trial would pull focus from its enforcement action.

  9. July 27, 2018

    FTC Says Drugmakers Must Face AndroGel Antitrust Suit

    The Federal Trade Commission on Thursday told a Georgia federal court that several pharmaceutical companies aren't entitled to a second chance to escape from a nearly decade-old antitrust suit alleging they conspired to keep a generic version of the testosterone drug AndroGel off the market, because such a "turducken task" would entail litigating patent validity. 

  10. June 14, 2018

    Drugmakers Must Face FTC's AndroGel Antitrust Suit

    A Georgia federal judge largely refused Thursday to let a group of pharmaceutical companies out of a nearly decade-old antitrust multidistrict litigation from the Federal Trade Commission and private parties alleging that they conspired to keep generic competitors for testosterone drug AndroGel off the market.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!